This federal contract award, with ID SPE2DP16D0002|0001, was issued by the Defense Logistics Agency (DLA) to the Canadian Commercial Corporation (CCC) for the delivery of pyridostigmine bromide, a medication used for nerve agent treatment. The $342,270.00 firm fixed-price delivery order contract does not have a set-aside designation.
CCC is a Crown corporation owned by the Government of Canada that acts as a prime contractor to U.S. federal agencies, primarily the Department of Defense. CCC has been awarded numerous prime and sub-contract awards by various U.S. federal agencies, including the Naval Supply Systems Command, Naval Air Systems Command, and U.S. Army, for a wide range of products and services such as aircraft components, medical equipment, and ammunition. This contract award represents one of CCC's deliveries of critical medical supplies to support U.S. military readiness and operations.